Tell A Colleague

Help a colleague receive information about Next Choice®

Simply fill out the information in the spaces below to have a colleague receive information about Next Choice. Be sure that all the required information is provided. (Bold = Required)

Your Name:
Your E-mail Address:
The Name Of Your Colleague:
Your Colleague's E-mail Address:

Please note that the information you’ve provided will strictly be used to e-mail your colleague this message. It will not be stored or used for any other purpose such as signing you or your colleague to a mailing list to get more information.

Here’s the message you are about to send:

(The first name of your colleague)

I came across some information about Next Choice that might be of interest to you. To find out more, simply visit www.mynextchoice.com.

(Your name)

Click here to submit and send your message.

Important Safety Information

Next Choice® should not be used by women with a known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice should be evaluated for ectopic pregnancy. Next Choice is not effective in terminating an existing pregnancy, and does not protect against STI/HIV. Next Choice may alter the next expected menses, however, if menses is delayed beyond 1 week, pregnancy should be considered. The most common adverse reactions in the clinical trial were menstrual changes (26%), nausea (23%), abdominal pain (18%), fatigue (17%), headache (17%), dizziness (11%), and breast tenderness (11%).

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.

This Web site is intended for United States Prescribers, Pharmacists & Consumers.